Medical Condition News

RSS

Rural beneficiaries more likely to undergo joint replacement surgeries than urban recipients

Southern Illinois University researchers determined Medicare beneficiaries living in rural areas were 27% more likely than urban recipients to have total knee or hip replacement surgeries.

30 Nov 2009

CCAC congratulates the Ontario government for expanding access to Avastin

The Colorectal Cancer Association of Canada (CCAC) applauds the Ontario Ministry of Health and Long-Term Care's decision today to provide expanded access of Avastin (bevacizumab) to patients with metastatic colorectal cancer.

30 Nov 2009

Study on deaths from cancer in Europe shows steady decline in mortality

New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.

29 Nov 2009

Leading mental health experts to hold conference in Vancouver

Leading experts in the field of mental health are holding one of the largest conferences of its kind in Vancouver, November Sunday 29 - Tuesday December 1. The conference, titled 'Into the Light,' is being jointly organized by the Mental Health Commission of Canada, Vancouver Coastal Health and Simon Fraser University and will be looking at mental health issues across Canada.

28 Nov 2009

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

ChemGenex Pharmaceuticals Limited announced today that the European Medicines Agency ("EMEA") has determined that the Marketing Authorization Application ("MAA") for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.

28 Nov 2009

Cromoz's new drug delivery system to reduce amount of drugs used in cancer treatment

Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a drug delivery vehicle with the ability to target the cancer site which has the potential to increase the drug efficacy.

28 Nov 2009

XenaCare Holdings becomes national sponsor of Arthritis Foundation

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that is has become a national sponsor of the Arthritis Foundation at the National Proud Sponsor level.

27 Nov 2009

European Commission approves MICARDIS medication for CV protection

MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.

27 Nov 2009

Combination of CPR and AED saves boy's life

A 13-year old male student attending James Keating Elementary School is alive today thanks to the partnership between the Heart and Stroke Foundation of Ontario and the County of Simcoe Paramedic Services.

27 Nov 2009

Bobby Moore Fund launches 'Project South Africa' to raise critical funds for bowel cancer research

The Bobby Moore Fund for Cancer Research UK is offering up to 40 participants a travel experience with a difference to the beautiful Republic of South Africa, just months before the country hosts the World Cup.

27 Nov 2009

Researchers predict diabetes cases to double and cost to triple in the next 25 years

The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.

27 Nov 2009

Cancer Research UK launches Little Star Awards in partnership with TK Maxx

THE COURAGE of British children who've encountered cancer is to be recognised with a unique award backed by celebrities including Leona Lewis, the Jonas Brothers and athletics phenomenon Usain Bolt.

27 Nov 2009

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers.

27 Nov 2009

CyberKnife Robotic Radiosurgery treatment offers new option for cancer patients in Ontario

Ontario marks a milestone with the announcement of the province's first CyberKnife Robotic Radiosurgery treatment option for cancer patients at Juravinski Cancer Centre. The technology will offer many cancer patients an effective alternative to surgery for some cancers.

26 Nov 2009

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.

26 Nov 2009

UCLA engineers and physicians develop PAD treatment device to prevent thrombosis

A fortuitous discovery that grew out of a collaboration between UCLA engineers and physicians could potentially offer hope to the nearly 10 million Americans who suffer from peripheral arterial disease.

26 Nov 2009

UGR scientists provide early diagnosis of eye disorders through optical technique

Researchers from the University of Granada have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

26 Nov 2009

Wnt signaling pathway plays a role in diabetic retinopathy

A group led by Dr. Jian-xing Ma at The University of Oklahoma Health Sciences Center, Oklahoma City, OK has demonstrated that the Wnt signaling pathway plays a role in diabetic retinopathy.

26 Nov 2009

BodyLogicMD opens 13 new bioidentical hormone specialty practices in 2009

For many businesses, 2009 has been a painful year. Not so for BodyLogicMD. The nation's largest and fastest growing network of expert physicians specializing exclusively in medically supervised bioidentical hormones has grown the number of physicians in its network since November 2008 - from 21 to 36 physicians - and is in progress to add more physician-owned centers, including one in Puerto Rico, by the end of this year.

26 Nov 2009

LCA-CA issues 2nd Annual Report Card on Lung Cancer

Today, Lung Cancer Alliance-California (LCA-CA) issued its 2nd Annual Report Card on Lung Cancer. The 2009 Report Card is an assessment of progress being made against this lethal disease in the state of California.

26 Nov 2009

Medical Condition News

Rural beneficiaries more likely to undergo joint replacement surgeries than urban recipients

CCAC congratulates the Ontario government for expanding access to Avastin

Study on deaths from cancer in Europe shows steady decline in mortality

Leading mental health experts to hold conference in Vancouver

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

Cromoz's new drug delivery system to reduce amount of drugs used in cancer treatment

XenaCare Holdings becomes national sponsor of Arthritis Foundation

European Commission approves MICARDIS medication for CV protection

Combination of CPR and AED saves boy's life

Bobby Moore Fund launches 'Project South Africa' to raise critical funds for bowel cancer research

Researchers predict diabetes cases to double and cost to triple in the next 25 years

Cancer Research UK launches Little Star Awards in partnership with TK Maxx

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

CyberKnife Robotic Radiosurgery treatment offers new option for cancer patients in Ontario

MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke

UCLA engineers and physicians develop PAD treatment device to prevent thrombosis

UGR scientists provide early diagnosis of eye disorders through optical technique

Wnt signaling pathway plays a role in diabetic retinopathy

BodyLogicMD opens 13 new bioidentical hormone specialty practices in 2009

LCA-CA issues 2nd Annual Report Card on Lung Cancer

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News